The Spine Department, Orthopaedic Center, Guangdong Second Provincial General Hospital, Guangzhou, China.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Stem Cell Res Ther. 2020 Jun 3;11(1):212. doi: 10.1186/s13287-020-01724-5.
The therapeutic effects of adipose-derived mesenchymal stem cell (ADSC) transplantation have been demonstrated in several models of central nervous system (CNS) injury and are thought to involve the modulation of the inflammatory response. However, the exact underlying molecular mechanism is poorly understood. Activation of the Jagged1/Notch signaling pathway is thought to involve inflammatory and gliotic events in the CNS. Here, we elucidated the effect of ADSC transplantation on the inflammatory reaction after spinal cord injury (SCI) and the potential mechanism mediated by Jagged1/Notch signaling pathway suppression.
To evaluate the therapeutic effects of ADSC treatment and the potential inhibitory effects of ADSCs on Notch signaling, mice were subjected to contusion SCI, and GFP-labeled ADSCs were injected into the lesion site immediately after the injury. Locomotor function, spinal cord tissue morphology, and the levels of Notch-related proteins and proinflammatory transcripts were compared between groups. To validate the hypothesis that the therapeutic effects of ADSCs are partly due to Notch1 signaling inhibition, a Jagged1 small interfering RNA (siRNA) was injected into the spinal cord to knock down Jagged1/Notch signaling. Neuronal staining and analyses of microglia/macrophage activation and signaling pathways were performed.
We demonstrated that ADSCs survived in the injured spinal cord for at least 28 days without differentiating into glial or neuronal elements. ADSC treatment resulted in significant downregulation of proinflammatory mediator expression and reduced ionized calcium-binding adapter molecule 1 (IBA1) and ED-1 staining in the injured spinal cord, eventually improving functional recovery. The augmentation of the Jagged1/Notch signaling pathway after SCI was suppressed by ADSC transplantation. The inhibition of the Jagged1/Notch signaling pathway by Jagged1 siRNA resulted in decreases in SCI-induced proinflammatory cytokines and the activation of microglia and an increase in the survival of neurons. Furthermore, Jagged1 knockdown suppressed the phosphorylation of JAK/STAT3 in astrocytes following SCI.
The results of this study demonstrated that the therapeutic effects of ADSCs in SCI mice were partly due to Jagged1/Notch signaling pathway inhibition and a subsequent reduction in JAK/STAT3 phosphorylation in astrocytes.
脂肪间充质干细胞(ADSC)移植在多种中枢神经系统(CNS)损伤模型中已显示出治疗效果,被认为涉及炎症反应的调节。然而,其确切的潜在分子机制尚不清楚。Jagged1/Notch 信号通路的激活被认为涉及 CNS 中的炎症和神经胶质事件。在这里,我们阐明了 ADSC 移植对脊髓损伤(SCI)后炎症反应的影响,以及 Jagged1/Notch 信号通路抑制介导的潜在机制。
为了评估 ADSC 治疗的治疗效果以及 ADSC 对 Notch 信号的潜在抑制作用,我们将 GFP 标记的 ADSC 注射到损伤部位,立即在 SCI 后注射到损伤部位。通过比较各组之间的运动功能、脊髓组织形态、Notch 相关蛋白和促炎转录本的水平来评估 ADSC 治疗的治疗效果。为了验证 ADSC 的治疗效果部分归因于 Notch1 信号抑制的假设,Jagged1 小干扰 RNA(siRNA)被注射到脊髓中以敲低 Jagged1/Notch 信号。进行神经元染色和小胶质细胞/巨噬细胞激活以及信号通路分析。
我们证明 ADSC 在受伤的脊髓中至少存活 28 天,而不会分化为神经胶质或神经元。ADSC 治疗导致促炎介质表达的显著下调,并减少受伤脊髓中离子钙结合接头分子 1(IBA1)和 ED-1 染色,最终改善功能恢复。SCI 后 Jagged1/Notch 信号通路的增强被 ADSC 移植抑制。Jagged1 siRNA 抑制 Jagged1/Notch 信号通路导致 SCI 诱导的促炎细胞因子减少,小胶质细胞激活增加,神经元存活增加。此外,Jagged1 敲低抑制了 SCI 后星形胶质细胞中 JAK/STAT3 的磷酸化。
这项研究的结果表明,ADSC 在 SCI 小鼠中的治疗效果部分归因于 Jagged1/Notch 信号通路抑制以及随后星形胶质细胞中 JAK/STAT3 磷酸化的减少。